¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium excreting factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antisterility factor
    Ç׺ÒÀÓÀÎÀÚ
  • atrial natriuretic factor
    ½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ, ½É¹æ¼ÒµãÀÌ´¢ÀÎÀÚ
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • alveolar dilution factor
    ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
  • amplification factor
    ÁõÆøÀÎÀÚ
  • behavioral risk factor
    ÇൿÀ§Çè¿äÀÎ
  • coagulation factor
    ÀÀ°íÀÎÀÚ
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • colony-stimulating factor
    Áý¶ôÀÚ±ØÀÎÀÚ
  • common factor
    °øÅëÀÎÀÚ
  • competence factor
    1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
  • competence inducing factor
    ¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
  • complementary factor
    º¸ÃæÀÎÀÚ
  • conglutinogen activating factor
    ±³Âø¿øÈ°¼ºÀÎÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • predisposing factor
    ¼±Çà¿äÀÎ
  • prognostic factor
    ¿¹ÈÄÀÎÀÚ
  • psychological factor
    ½É¸®¿ä¼Ò
  • relaxing factor
    ÀÌ¿ÏÀÎÀÚ
  • resistance factor
    ³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
  • rheumatoid factor
    ·ù¸¶Æ¼½ºÀÎÀÚ
  • risk factor
    À§ÇèÀÎÀÚ
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antiscorbutic factor
    Ç×±«Ç÷º´ÀÎÀÚ
  • antisterility factor
    Ç׺ÒÀÓÀÎÀÚ
  • atrial natriuretic factor
    ½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ
  • colonizing factor antigen
    Áý¶ôÇü¼ºÀÎÀÚÇ׿ø
  • behavioral risk factor
    ÇൿÀ§Çè¿äÀÎ
  • carcinogenic factor
    ¹ß¾ÏÀÎÀÚ
  • chemotactic factor
    È­ÇÐÁÖ¼ºÀÎÀÚ, È­Çнò¸²ÀÎÀÚ
  • coagulation factor
    ÀÀ°íÀÎÀÚ
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • colony-stimulating factor
    Áý¶ôÀÚ±ØÀÎÀÚ
  • common factor
    °øÅëÀÎÀÚ
  • competence factor
    Àû°ÝÀÎÀÚ
  • competence inducing factor
    Àû°ÝÀ¯¹ßÀÎÀÚ
  • complementary factor
    º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
  • conglutinogen activating factor
    ±³Âø¿øÈ°¼ºÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • EDCF (endothlium-derived contracting factor)
    ³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í­)
  • EDRF (endothlium-derived relaxing factor)
    ³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í­)
  • EDRF=£¾endothelium derived relaxing factor
    ³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
  • F factor
    FÀÎÀÚ
  • Factor IX
    IX ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor V
    V ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor VII
    VII ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor VIII
    VIII ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor X activated
    Ȱ¼ºÈ­(üÀàõûù)µÈ X ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor XI
    XI ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Factor XII
    XII ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Fibrin-stabilizing factor
    ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡­äÌïÒì×í­)
  • Fibroblast growth factor
    ¼¶À¯¸ð¼¼Æ÷(àéë«Ù½á¬øà)¼ºÀå¿äÀÎ(à÷íþé©ì×)
  • G-CSF (Granulocyte colony-stimulating factor)
    °ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í­)
  • GH releasing factor
    ¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natrium =sodium
    ³ªÆ®·ý.
  • nonexchangeable sodium
    ºñ±³È¯¼º ³ªÆ®·ý.
  • phethenylate sodium
    ÆäÅ×´Ò·¹ÀÌÆ®³ªÆ®·ý.
  • simple sodium depletion
    ´Ü¼øNa<³ªÆ®·ý>ºÎÁ·.
  • soda = sodium bicarbonate
  • sodium
    ¼Òµð¿ò
  • sodium
    ³ªÆ®·ý.
  • sodium
    ³ªÆ®·ý(¡­), ¼Òµã(¡­)
  • sodium acetate formalin
    ¾Æ¼¼Æ®»ê³ªÆ®·ý Æ÷¸£¸»¸°
  • sodium balance
    ¼Òµð¿òÆòÇü.
  • sodium bicarbonate test
    ÁßÁ¶½ÃÇè
  • sodium carrier
    ³ªÆ®·ý¿î¹Ýü(¡­ê¡Úæô÷).
  • sodium channel
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium chloride balance test
    ¿°È­³ªÆ®·ýÆòÇü½ÃÇè(¡­øÁû¬ãËúÐ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antianemia factor
    Ç׺óÇ÷ÀÎÀÚ(ù÷Þ¸úìì×í­)
  • antiberiberi factor
    Ç×°¢±âÀÎÀÚ(ù÷ÊÅѨì×í­)
  • antiblack-tongue factor
    Ç×Èæ¼³ÀÎÀÚ(ù÷ýÙàßì×í­)
  • antihemophilic factor
    Ç×Ç÷¿ìº´ÀÎÀÚ(ù÷úìéÒÜ»ì×í­)
  • antihemophilic factor B
    Ç×Ç÷¿ìº´ÀÎÀÚ (ù÷úìéÒÜ»ì×í­) B
  • antihemophilic factor C
    Ç×Ç÷¿ìº´ÀÎÀÚ (ù÷úìéÒÜ»ì×í­) C
  • antineuritic factor
    Ç׽Ű漺ÀÎÀÚ(ù÷ãêÌèàõì×í­)
  • antinuclear factor
    Ç×ÇÙÀÎÀÚ(ù÷ú·ì×í­)
  • antipellagra factor
    Ç×(ù÷)Æç¶ó±×¶ó ÀÎÀÚ(ì×í­)
  • antipeptic ulcer factor
    Ç×(ù÷)±Ë¾ç(Ï÷åË) ÀÎÀÚ(ì×í­)
  • antipernicious anemia factor
    Ç×(ù÷)¾Ç¼ººóÇ÷(äÂàõÞ¸úì) ÀÎÀÚ(ì×í­)
  • antiscorbutic factor
    Ç×±«Ç÷º´ÀÎÀÚ(ù÷ÎÕúìÜ»ì×í­)
  • antisigma factor
    Ç×(ù÷)½Ã±×¸¶ ÀÎÀÚ(ì×í­)
  • antispecificity factor
    Çׯ¯À̼º ÀÎÀÚ(ù÷÷åì¶àõì×í­)
  • antisterility factor
    Ç׺ÒÀÓ ÀÎÀÚ(ù÷ÝÕìõì×í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TF free thyroxine; tactile fremitus; tail flick [reflex]; temperature factor; testicular feminization; ...
DOSS distal over-shoulder strap; dioctyl sodium sulfosuccinate; docusate sodium
DSS dengue shock syndrome; dioctyl sodium sulfosuccinate; Disability Status Scale; discrete subaortic st...
PSL parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu...
SB Bachelor of Science; Schwartz-Bartter [syndrome]; serum bilirubin; shortness of breath; sick bay; si...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DSS Dextran sodium sulfate
DSS Dextran sulfate sodium
DSS Dextran sulphate sodium
DS Diclofenac sodium
DSS Dioctyl sodium sulfosuccinate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium alginate
    ¾ËÁø»ê ³ªÆ®·ý
    ¾à ¾ËÄ®¸®¸¦ »ç¿ëÇÏ¿© °¥»ö ÇØÃʷκÎÅÍ ÃßÃâ Á¤Á¦µÈ ź¼öÈ­¹° ÇöŹ¾× ¿ëÁ¦·Î ¾²ÀδÙ. ¶ÇÇÑ À¯È­ ÀÛ¿ë, ¾ÈÁ¤È­ ÀÛ¿ë, ³óÈ­ ÀÛ¿ë, ¼ö°áÇÕ ÀÛ¿ëÀ» °¡ÁüÀ¸·Î½á À½½Ä¹°, ÀǾàǰ, È­Àåǰ µî¿¡ »ç¿ëµÈ´Ù.
  • sodium benzoate
    ¾È½ÄÇâ»ê ³ªÆ®·ý
    ¾È½ÄÇâ»êÀÇ ³ªÆ®·ý¿°. ¹é»öÀÇ °ú¸³»ó ¶Ç´Â °áÁ¤¼º ºÐ¸». Ç×Áø±Õ¼º ¾àǰ. °£ ±â´É °Ë»ç¿ëÀ¸·Î »ç¿ëµÈ´Ù.
  • sodium biphosphate
    ÀÌÀÎ»ê ³ªÆ®·ý
    ÀλêÀÇ monohydrate ÀÏ ³ªÆ®·ý¿°. ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Ç×Ä®½· °úÀ× Ç÷Á¦, ¼³»ç ¾àÀ¸·Î¼­ ÀÎ»ê ³ªÆ®·ý°ú ÇÔ²² Åõ¿©µÈ´Ù. ¿äÀÇ »ê¼ºÈ­Á¦·Îµµ ¾²ÀδÙ.
  • sodium bisulfite
    Áß¾ÆÈ²»ê ³ªÆ®·ý
    ¾ÆÈ²»ê ¼ö¼Ò ³ªÆ®·ý. ¿©·¯ °¡ÁöÀÇ Á¦¾à¿¡ Ç×»êÈ­Á¦·Î »ç¿ëµÈ´Ù.
  • sodium carbonate
    ź»ê ³ªÆ®·ý
    ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Á¦¾×¿¡¼­ ¾ËÄ®¸®È­ ¾àǰÀ¸·Î »ç¿ëÇÑ´Ù. ¶ÇÇÑ Àμ³À» ÀÏÀ¸Å°´Â ÇǺκ´ÀÇ Ä¡·á¿¡ »ç¿ëÇϸç, ¼¼Á¤Á¦·Îµµ ¾²ÀδÙ.
  • sodium citrate
    ±¸¿¬»ê ³ªÆ®·ý
    C6H5Na3O7. ±¸¿¬»êÀÇ »ï³ªÆ®·ý¿°.
  • sodium exchange resin
    ³ªÆ®·ý ±³È¯ ¼öÁö, ¼Òµð¿ò ±³È¯ ¼öÁö
  • sodium fluoride denitifrice
    ºÒÈ­ ³ªÆ®·ý Ä¡¾à
  • sodium glutamate
    ±Û·çŸ¹Î»ê ³ªÆ®·ý
    ¾Æ¹Ì³ë»êÀÇ ÇϳªÀÎ L-±Û·çŸ¹Î»êÀÇ ³ªÆ®·ý¿°. ÁÁÀº ¸ÀÀ» Áö³à Á¶¹Ì·á·Î¼­ Àß ¾Ë·ÁÁ® ÀÖ´Ù. D-ü´Â Ưº°ÇÑ ¸ÀÀ» Áö´Ï°í ÀÖÁö ¾Ê´Ù. l-±Û·çŸ¹Î»êÀº ³ú ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ¾Ï¸ð´Ï¾Æ¿Í °áÇÕÇØ ±Û·çŸ¹ÎÀÌ µÇ¹Ç·Î ÀúÇ÷´ç È¥¼ö, °£¼º È¥¼ö ½Ã³ª ¾Ï¸ð´Ï¾Æ ÇØµ¶¿¡ »ç¿ëÇÑ´Ù. ´Ù·® »ç¿ë ½Ã¿¡´Â ¾ËÄ®·Î½Ã½º, ¿À½É, ±¸Åä, µÎºÎ ¾Ð¹Ú°¨, µÎÅë µîÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖ´Ù. À̰ÍÀº Á¶¹Ì·á¸¦ ´Ù·® »ç¿ëÇÏ´Â ÁßÈ­ ¿ä¸®¸¦ ¸ÔÀº µÚ¿¡ ÀϾ´Â Á¡¿¡¼­ ÁßÈ­ ¿ä¸®Á¡ ÁõÈıº
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý
    ¹é»öÀÇ °íü. ÀÛ°í µÕ±Ù ¸ð¾ç, ¹ÚÆí ¸ð¾ç, ¸·´ë ¸ð¾ç µî ¿©·¯ ¸ð¾çÀ¸·Î Á¸ÀçÇÑ´Ù. °­ÇÑ ¾ËÄ®¸®¼º. Á¦¾×¿¡¼­ ¾ËÄ®¸®È­Á¦·Î »ç¿ëÇÑ´Ù.
  • sodium hypochlorite
    Â÷¾Æ¿°¼Ò»ê ³ªÆ®·ý
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium monofluorophosphate
    ÀÏ ºÒ¼Ò ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=
  • sodium nitrate
    ¾ÆÁú»ê ³ªÆ®·ý
    ¹é»öÀ̳ª ¾à°£ ³ë¶õ»öÀÇ °ú¸³¼º ºÐ¸», ¹é»öÀÇ ºÒÅõ¸íÇÑ ¿ëÀ¶ µ¢¾î¸® ¶Ç´Â ¸·´ë ¸ð¾ç. û»ê Ä®¸® Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦·Î »ç¿ëÇÑ´Ù. Çù½ÉÁõ, õ½ÄÀÇ °æ¿ì¿¡µµ »ç¿ëµÇ¸ç, º¹Åë, °æ·Ã¼º ´ëÀå¿°°ú °°Àº »óÅ¿¡µµ ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sodium perborate
    °úºØ»ê ³ªÆ®·ý
    ºØ»êÀ̳ª ºØ»ê³ªÆ®·ýÀÌ ³ªÆ®·ý ¶Ç´Â °ú»êÈ­ ¼ö¼Ò¿Í »óÈ£ÀÛ¿ëÇÏ¿© »ý¼ºµÈ È­ÇÕ¹°, ¹æºÎÁ¦. 2% ¿ë¾×À¸·Î´Â ¾çÄ¡Áú ¾×À¸·Îµµ »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
ceftizoxime sodium C13H12N5NaO5S2;a broad spectrum cephalosporin antibiotic similar to cefotaxime sodium.
(05 Mar 2000)
glucosulfone sodium P,p'-Sulfonyldianiline N,N'-diglucoside disodium;a chemotherapeutic agent used in the treatment of leprosy; parenteral administration is better tolerated than oral administration.
(05 Mar 2000)
glucosulphone sodium <drug> A drug used to treat the disease leprosy. It has the chemical formula of C24H34N2Na2O18S3.
It is a yellowish white solid, a solution of which is intravenously injected into the patient.
(09 Oct 1997)
resorcinolphthalein sodium A dye used for diagnosis of certain ocular diseases, differentiation or delineation of organ parts in surgery, and determination of circulation time.
Synonym: resorcinolphthalein sodium, uranin.
(05 Mar 2000)
glycocholate sodium A normal constituent of bile of man and herbivores; glycocholate sodium from herbivores is purified and used as a choleretic and cholagogue.
(05 Mar 2000)
cephapirin sodium A semisynthetic broad spectrum antibiotic derived from cephalosporin C; it is used by injection.
(05 Mar 2000)
penicillin G sodium <drug> The sodium salt of penicillin G, containing not less than 85% penicillin G.
Synonym: Sodium benzylpenicillin
(05 Mar 2000)
gold sodium thiomalate <chemical> A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
Pharmacological action: antirheumatic agents, gold.
Chemical name: Butanedioic acid, mercapto-, monogold(1+) sodium salt
(12 Dec 1998)
gold sodium thiosulfate <chemical> An antirheumatic agent with the same actions and uses as gold sodium thiomalate.
Pharmacological action: antirheumatic agents, gold.
Chemical name: Aurate(3-), bis(monothiosulfato(2-)-O,S)-, trisodium, (T-4)-
(12 Dec 1998)
menadiol sodium diphosphate Tetrasodium 2-methyl-1,4-naphthalenediol-bis(dihydrogen phosphate);a dihydro derivative of menadione, with similar vitamin K activity.
(05 Mar 2000)
menadione sodium bisulfite It possesses the same action and is used for the same purposes as menadione or vitamin K; it differs, however, from menadione in being water-soluble.
(05 Mar 2000)
mercaptomerin sodium N-(gamma-Carboxymethylmercaptomercuri-beta-methoxy)propylcamphoramic acid disodium salt;a mercurial diuretic.
(05 Mar 2000)
mercurophylline sodium The sodium salt of beta-methoxy-gamma-hydroxymercuripropylamide of trimethylcyclopentanedicarboxylic acid, and theophylline; a mercurial diuretic.
(05 Mar 2000)
chloramphenicol sodium succinate <chemical> Chloramphenicol-alpha-(sodium succinate);the water-soluble sodium succinate derivative of chloramphenicol, suitable for parenteral administration; antibacterial activity, uses, and side effects are similar to those of the parent compound.
(05 Mar 2000)
cholistine sulphomethate sodium Pentasodium colistinmethanesulfonate;contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component, with a small proportion of the pentasodium salt of the same derivative of colistin B; an effective antibiotic against most Gram-negative bacilli (except Proteus), given intramuscularly.
See: colistin sulfate, polymyxin.
Synonym: cholistine sulphomethate sodium, colistin sulfomethate sodium.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • coal-factor
    ¼®Åº Áß°³ »óÀÎ(µµ¸Å »óÀÎ)
  • common factor
    =COMMON DIVISOR
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • factor
    ¿ä¼Ò;¿äÀÎ;¿øÀÎ;Àμö;ÀÎÀÚ;°è¼ö;À²;´ë¸®»ó;µµ¸Å»ó;Á߸ÅÀÎ
  • factor analysis
    ÀÎÀÚ ºÐ¼®
  • factor cost
    ¿äÀÎ(¿ä¼­)ºñ¿ë
  • intrinsic factor
    (»ýÈ­)³»À缺ÀÎÀÚ
  • nerve growth factor
    (»ý¸®)½Å°æ ¼ºÀåÀÎÀÚ(Áö°¢(±³°¨)½Å°æ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ´Ü¹éÁú)
  • noise factor(figure)
    (ÁõÆø±â¿¡¼­ÀÇ)ÀâÀ½Áö¼ö
  • pp factor
    Ç× Æç¶ó±×¶ó ÀÎÀÚ(Æç¶ó±×¶ó ¿¹¹æ¿¡ ¾²´Â ´ÏÄÚÆ¾»ê,´ÏÄÚÆ¾»ê¸¶À̵å)
  • prime factor
    ¼ÒÀμö
  • releasing factor
    È£¸£¸ó ¹æÃâÀÎÀÚ
  • rheumatoid factor
    ·ù¸ÓƼÁòÀÎÀÚ(¸¸¼º °üÀý ·ù¸ÓƼÁò ȯÀÚÀÇ ÀÚ±â Ç×ü)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á